HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents
Cover Story

Prospective trials, society guidelines offer new insights into cancer-associated thrombosis

Point/Counter

Should anticoagulation for cancer-associated thrombosis extend beyond 6 months?

Editorial

TGIF 2018: The gut and immune function

Derek Raghavan, MD, PhD

Commentary

Cancer survivorship care has ‘crucial impact’ on patients’ overall well-being

David L. Jennings II, MSN, RN, AGPCNP-BC

Tumor subtype, location should guide MRI surveillance after soft tissue sarcoma excision

Christopher N. Johnson, DO; Matthew J. Thompson, MD

Imaging Analysis

Carotid space lesions: Added value of 68Gallium-DOTATATE PET/MRI

Ana M. Franceschi, MD; Munir Ghesani, MD

Meeting News

Brentuximab vedotin before, after chemotherapy improves survival for older patients with Hodgkin lymphoma

Brentuximab vedotin, nivolumab combination appears active for Hodgkin lymphoma

Collaboration bridges gap between patients supportive oncology care

Opioid use steady among younger patients with sickle cell disease

Ramucirumab reduces risk for progression in certain gastric cancers

Robot-assisted thoraco-laparoscopic esophagectomy reduces complications

Nivolumab plus ipilimumab demonstrates clinical benefit for certain metastatic colorectal cancers

Liquid biopsy test detects early-stage colorectal cancer

Invasive fungal infections uncommon among children with acute lymphoblastic leukemia

Voxelotor improves hemoglobin levels, hemolysis markers in sickle cell disease

Engineered stem cells may provide ‘universal’ donor cells for sickle cell disease

Tisagenlecleucel induces durable responses in relapsed, refractory DLBCL

Duvelisib extends PFS in relapsed or refractory chronic lymphocytic leukemia

'Future looks bright' for combination of venetoclax, obinutuzumab in chronic lymphocytic leukemia

Chronic graft-versus-host disease triples risk for morbidity, frailty among transplant survivors

Dual HER-2 therapy with trastuzumab, lapatinib improves EFS

Study reveals genetic differences in recurrent vs. primary tumors

Ribociclib improves PFS in younger women with advanced breast cancer

Temporary ovarian suppression preserves fertility during chemotherapy

Trabectedin maintains safety, efficacy for older patients with advanced soft tissue sarcoma

In the Journals Plus

PTSD common after cancer diagnosis

Chemotherapy use declines in early-stage breast cancer

Long-term birth control use reduces risk for ovarian, endometrial cancers

Survivors of head, neck cancer more likely to die of competing causes

Childhood chemotherapy may decrease cognitive function in young adults

Educational video improves hairdressers’ ability to detect skin cancer

Older patients with HIV at higher risk for cancer

Elevated biomarker level postoperatively increases colon cancer recurrence risk

Certain BRAF mutations improve prognosis in colorectal cancer

Androgen deprivation therapy does not increase risk for Alzheimer’s disease, dementia

Older men less likely to receive definitive therapy for prostate cancer

Surgery extends survival in early-stage lung cancer

Osimertinib superior to standard first-line treatments for EGFR-mutated lung cancer

Partial-breast radiotherapy may spare women of ‘physical discomfort, emotional distress’

FDA News

FDA approves Lynparza, first treatment for BRCA-mutated breast cancer

FDA approves Opdivo for resected melanoma

FDA approves Perjeta-based regimen for adjuvant treatment of early breast cancer

FDA approves Xgeva for prevention of skeletal-related events in multiple myeloma

FDA clears stereotactic radiotherapy system for breast cancer

FDA expands approval of Bosulif for chronic myelogenous leukemia

FDA grants breakthrough designation to Bavencio plus Inlyta for renal cell carcinoma

FDA grants breakthrough therapy designation to voxelotor for sickle cell disease

FDA grants orphan drug designation to CG’806 for acute myeloid leukemia

FDA resources can help prescribers better understand biosimilars

FDA grants priority review to multiple hematology/oncology agents

Lymphoma specialist named associate director for clinical services at Rutgers Cancer Institute

Multifacility blood transfusion management program led to $2 million in annual savings

Multivitamins may reduce risk for chemotherapy-induced peripheral neuropathy

Pediatric oncologist named executive director of Israel Cancer Research Fund

Physician-researcher joins Atlantic Health System

Roswell Park Comprehensive Cancer Center appoints several leaders

Smartphone app helps screen for pancreatic cancer

CHIP funding renewed for 6 years

Opioid emergency declarations offer short-term benefit on a ‘slippery slope’